2014, Number 3
<< Back Next >>
Dermatología Cosmética, Médica y Quirúrgica 2014; 12 (3)
Cutaneous mastocytosis in twins: a 12-year follow-up
Fernando GC, Mosquera T, Prahl P
Language: Spanish
References: 19
Page: 179-181
PDF size: 142.25 Kb.
ABSTRACT
Urticaria pigmentosa is the most common form of cutaneous
mastocytosis, a sporadical entity that seldom affects twins. This
report describes a 12-year follow-up of monozygotic twins.
REFERENCES
Fett NM, Teng J, Longley BJ. “Familial urticaria pigmentosa: report of a family and review of the role of kit mutations”. Am J Dermatopathol. 2013; 35(1): 113-116.
De la Sotta P, Romero WA, Kramer D, Cárdenas C, González S. “Cutaneous mastocytosis in twins: multiple mastocytomas and urticaria pigmentosa in two pairs of monozygotic twins”. Pediatr Dermatol 2011; 28(5): 585-587.
Sato-Matsumura KC, Matsumura T, Koizumi H, Sato H, Nagashima K, Ohkawara A. “Analysis of c-kit exon 11 and exon 17 of urticaria pigmentosa that occurred in monozygotic twin sisters. Br J Dermatol. 1999; 140(6): 1130-1132.
Boyano T, Carrascosa T, Val J, Porta N, Agud JL, Garcia MJ. “Urticaria pigmentosa in monozygotic twins”. ArchDermatol 1990; 126(10): 1375-1376
Offidani A, Cellini A, Simonetti O, Bossi G. “Urticaria pigmentosa in monozygotic twins”. Arch Dermatol 1994; 130(7): 935-936.
Pec J, Palencarova E, Malisova S, Dobrota D, Hajtman A, Pec M, Lepej J. “Urticaria pigmentosa in identical male twins”. Acta Derm Venereol 1995; 75(3): 244.
Noto G, Pravatà G, Aricò M. “Concordant urticaria pigmentosa in a couple of identical twins. A five-year follow-up”. Acta Derm Venereol 1995; 75(6): 499.
Ravella A, Pujol RM, Noguera X, de Moragas JM. “Urticaria pigmentosa in 2 monozygotic twins”. Ann Dermatol Venereol 1986; 113(12): 1231-1234.
Kuan YZ. “Urticaria pigmentosa in two pairs of monozygotic twins”. J Dermatol. 1979; 6(6): 375-378.
Rockoff AS. “Urticaria pigmentosa in identical twins”. Arch Dermatol 1978; 114(8): 1227-1228.
Gay MW, Noojin RO, Finley WH. “Urticaria pigmentosa discordant in identical twins”. Arch Dermatol 1970; 102(1): 29-33.
Wasag B, Niedoszytko M, Piskorz A, Lange M, Renke J, Jassem E, Biernat W, Debiec-Rychter M, Limon J. “Novel, activating kit-N822I mutation in familial cutaneous mastocytosis”. Exp Hematol 2011; 39(8): 859-865.
Foster R, Byrnes E, Meldrum C, Griffith R, Ross G, Upjohn E, Braue A, Scott R, Varigos G, Ferrao P, Ashman LK. “Association of pediatric mastocytosis with apolymorphism resulting in an aminoacid substitution (M541L) in the transmembrane domain of c-kit”. Br J Dermatol 2008; 159(5): 1160-1169.
Uzzaman A, Maric I, Noel P, Kettelhut BV, Metcalfe DD, Carter MC. “Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology”. Pediatr Blood Cancer 2009; 53(4): 629-634.
Heide R, Tank B, Oranje AP. “Mastocytosis in childhood”. Pediatr Dermatol 2002; 19(5): 375-381.
Heide R, Beishuizen A, De Groot H, Den Hollander JC, Van Doormaal JJ, DeMonchy JG, Pasmans SG, Van Gysel D, Oranje AP; Dutch National Mastocytosis Work Group. “Mastocytosis in children: a protocol for management”. Pediatr Dermatol 2008; 25(4): 493-500.
Kanwar AJ, Sandhu K. “Cutaneous mastocytosis in children: an Indian experience”. Pediatr Dermatol 2005; 22(1): 87-89.
Correia O, Duarte AF, Quirino P, Azevedo R, Delgado L. “Cutaneous mastocytosis: Two pediatric cases treated with topical pimecrolimus”. Dermatol Online J 2010; 16(5): 8.
Agarwala MK, George R, Mathews V, Balasubramanian P, Thomas M, Nair S. “Role of imatinib in the treatment of pediatric onset indolent systemic mastocytosis: a case report. J DermatologTreat. 2013; 24(6): 481-483.